1. Home
  2. TIL vs CTGO Comparison

TIL vs CTGO Comparison

Compare TIL & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • CTGO
  • Stock Information
  • Founded
  • TIL 2018
  • CTGO 2009
  • Country
  • TIL United States
  • CTGO United States
  • Employees
  • TIL N/A
  • CTGO N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • CTGO Precious Metals
  • Sector
  • TIL Health Care
  • CTGO Basic Materials
  • Exchange
  • TIL Nasdaq
  • CTGO Nasdaq
  • Market Cap
  • TIL 134.5M
  • CTGO 135.7M
  • IPO Year
  • TIL 2021
  • CTGO N/A
  • Fundamental
  • Price
  • TIL $20.97
  • CTGO $11.46
  • Analyst Decision
  • TIL Strong Buy
  • CTGO Strong Buy
  • Analyst Count
  • TIL 4
  • CTGO 1
  • Target Price
  • TIL $114.00
  • CTGO $37.00
  • AVG Volume (30 Days)
  • TIL 103.6K
  • CTGO 117.1K
  • Earning Date
  • TIL 11-13-2024
  • CTGO 02-12-2025
  • Dividend Yield
  • TIL N/A
  • CTGO N/A
  • EPS Growth
  • TIL N/A
  • CTGO N/A
  • EPS
  • TIL N/A
  • CTGO N/A
  • Revenue
  • TIL N/A
  • CTGO N/A
  • Revenue This Year
  • TIL N/A
  • CTGO N/A
  • Revenue Next Year
  • TIL $2.65
  • CTGO $39.24
  • P/E Ratio
  • TIL N/A
  • CTGO N/A
  • Revenue Growth
  • TIL N/A
  • CTGO N/A
  • 52 Week Low
  • TIL $9.20
  • CTGO $9.65
  • 52 Week High
  • TIL $92.00
  • CTGO $25.32
  • Technical
  • Relative Strength Index (RSI)
  • TIL 46.36
  • CTGO 49.76
  • Support Level
  • TIL $18.56
  • CTGO $9.82
  • Resistance Level
  • TIL $22.00
  • CTGO $11.23
  • Average True Range (ATR)
  • TIL 1.98
  • CTGO 0.61
  • MACD
  • TIL 0.36
  • CTGO 0.36
  • Stochastic Oscillator
  • TIL 28.05
  • CTGO 94.27

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's primary focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Tetlin Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska.

Share on Social Networks: